Sankalp India Foundation is committed to improving the access to care and management for the children suffering from thalassemia. In order to ensure that each child walking into one of the centers supported by us gets adequate (if not at par with the best) care and management, we constantly strive to find solution to the most pressing problems of the management of this disorder.
The last edition of the Patrika laid the prelude to understanding and handling adverse events in outdoor voluntary blood donation drives.
Although blood donation is a safe and well established procedure, certain blood donors face an adverse reaction either during or post donation. The severity of such reactions varies from person to person. However, a general pattern of the nature can be drawn. Such reactions may discourage these donors from donating again.
Bangalore was happy to host the second annual conference of Indian Society for Transfusion Medicine from September 13-15 2013. The conference brought together the experts in the field of transfusion medicine from across the nation. It was a great opportunity to learn and share.
Although blood donation is a safe and well established procedure, certain blood donors face an adverse reaction either during or post donation. The severity of such reactions varies from person to person. However, a general pattern of the nature can be drawn. Such reactions may discourage these donors from donating again.
A critical step in the blood donation process is the medical screening of donors. Voluntary organisations and blood banks alike strive to ensure that the process of donating blood is safe for both the donor and the recipient. A commonly asked question in blood donation drives is if the donor has taken some tablets/medicines in the days prior to donation. American Association for Blood Banks lists some drugs commonly accepted in blood donors. This might be useful to avoid unnecessary deferrals.
High dose of human recombinant erythropoietin two days pre-op benefits cardiac surgery patients
WEDNESDAY, May 8 (HealthDay News) -- A single high dose of human recombinant erythropoietin (HRE) administered two days before cardiac surgery is associated with reduced need for transfused blood, according to a study presented at the annual meeting of the American Association for Thoracic Surgery, held from May 4 to 8 in Minneapolis.
Vikram is the first ever recipient of Haploidentical transplant in the country
When a 10-year-old has cancer, the boy’s family and doctors obviously have to do everything under the sun to find a cure for him. That is what parents and doctors of Vikram (name changed) of Madurai did. The hunt was on to find a 100 per cent matching donor, and when that failed, they found one that was a half match.
Vikram got a bone marrow transplant with a 50 per cent match from his mother. He survives to tell the tale today, speaking over a surgical mask.
